{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:49:51Z","timestamp":1787989791671,"version":"build-2784847793"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jsps.2020.08.020","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T03:42:51Z","timestamp":1599018171000},"page":"1301-1308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["An eco-friendly HPLC-UV method for the determination of risedronate in its bulk and tablet dosage form with application to content uniformity, dissolution and stability testing"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-0430","authenticated-orcid":false,"given":"Moustapha E.","family":"Moustapha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3585-0828","authenticated-orcid":false,"given":"Mehnaz","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-1637","authenticated-orcid":false,"given":"Rania M.","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"17","key":"10.1016\/j.jsps.2020.08.020_b0005","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1081\/JLC-200029351","article-title":"Stability indicating ion-pair HPLC method for the determination of risedronate in a commercial formulation","volume":"27","author":"Aluoch","year":"2004","journal-title":"J. Liq. Chromat. Rel. Tech."},{"key":"10.1016\/j.jsps.2020.08.020_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2014.09.016","article-title":"A novel automated hydrophilic interaction liquid chromatography method using diode-array detector\/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals","volume":"1365","author":"Bertolini","year":"2014","journal-title":"J. Chromat. A"},{"key":"10.1016\/j.jsps.2020.08.020_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/bcr414","article-title":"Development of bisphosphonates","volume":"4","author":"Fleisch","year":"2002","journal-title":"Breast Can. Res."},{"key":"10.1016\/j.jsps.2020.08.020_b0020","unstructured":"Food and Drug Administration and Food and Drug Administration, 1997. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Center for Drug Evaluation and Research (CDER), US Department of Health and Human Services."},{"issue":"7","key":"10.1016\/j.jsps.2020.08.020_b0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.trac.2010.03.009","article-title":"Green strategies for decontamination of analytical wastes","volume":"29","author":"Garrigues","year":"2010","journal-title":"TrAC \u2013 Trend Anal. Chem."},{"issue":"12","key":"10.1016\/j.jsps.2020.08.020_b0030","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1517\/14656566.2.12.2011","article-title":"Review of risedronate in the treatment of osteoporosis","volume":"2","author":"Geusens","year":"2001","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.jsps.2020.08.020_b0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchromb.2011.11.031","article-title":"Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography\/tandem mass spectrometry (LC-MS\/MS) for determination of risedronate concentrations in human plasma","volume":"88","author":"Ghassabian","year":"2012","journal-title":"J. Chromat. B"},{"key":"10.1016\/j.jsps.2020.08.020_b0040","doi-asserted-by":"crossref","first-page":"S777","DOI":"10.1016\/j.arabjc.2012.12.004","article-title":"Applying green analytical chemistry for rapid analysis of drugs: adding health to pharmaceutical industry","volume":"10","author":"Haq","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.jsps.2020.08.020_b0045","unstructured":"ICH Q2(R1) Validation of Analytical Procedures: Text and Methodology - ECA Academy [WWW Document], n.d. URL https:\/\/www.gmp-compliance.org\/guidelines\/gmp-guideline\/ich-q2r1-validation-of-analytical-procedures-text-and-methodology(accessed 3.26.20)."},{"issue":"2","key":"10.1016\/j.jsps.2020.08.020_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2006.01.077","article-title":"Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector","volume":"562","author":"Jia","year":"2006","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jsps.2020.08.020_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.aca.2006.11.012","article-title":"Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations","volume":"584","author":"Kyriakides","year":"2007","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jsps.2020.08.020_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1039\/an9911600003","article-title":"Basic statistical methods for analytical chemistry. Part 2. Calibration and regression methods. A review","volume":"116","author":"Miller","year":"1991","journal-title":"Analyst"},{"issue":"4","key":"10.1016\/j.jsps.2020.08.020_b0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2125.1999.00035.x","article-title":"The effect of dosing regimen on the pharmacokinetics of risedronate","volume":"48","author":"Mitchell","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsps.2020.08.020_b0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: From the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.jsps.2020.08.020_b0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/chromsci\/bmt105","article-title":"UPLC-UV method for determination of risedronate in human urine","volume":"52","author":"Seo","year":"2014","journal-title":"J. Chromat. Sci."},{"issue":"6","key":"10.1016\/j.jsps.2020.08.020_b0080","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1359\/jbmr.1998.13.6.1032","article-title":"Risedronate in the treatment of paget\u2019s disease of bone: An open label, multicenter study","volume":"13","author":"Siris","year":"1998","journal-title":"J. Bone Min. Res."},{"issue":"8","key":"10.1016\/j.jsps.2020.08.020_b0085","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1080\/10826076.2012.683919","article-title":"Development and validation of a stability indicating capillary electrophoresis method for the determination of risedronate in tablets","volume":"36","author":"Sun","year":"2013","journal-title":"J. Liq. Chromat. Rel. Tech."},{"key":"10.1016\/j.jsps.2020.08.020_b0090","unstructured":"United States Pharmacopoeia 30 \u2013 National Formulary 25. (n.d.). Retrieved May 5, 2020, from https:\/\/www.tsoshop.co.uk\/bookstore.asp?Action=Book&ProductId=9781889788470."},{"issue":"1","key":"10.1016\/j.jsps.2020.08.020_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1570-0232(03)00394-5","article-title":"Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection","volume":"794","author":"Vallano","year":"2003","journal-title":"J. Chromat. B"},{"issue":"4","key":"10.1016\/j.jsps.2020.08.020_b0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.59566\/IJBS.2008.4303","article-title":"Spectrophotometric determination of risedronate in pharmaceutical formulations via complex formation with Cu (II) ions: application to content uniformity testing","volume":"4","author":"Walash","year":"2008","journal-title":"Int. J. Biomed. Sci.: IJBS"},{"issue":"11","key":"10.1016\/j.jsps.2020.08.020_b0105","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/00032710902993795","article-title":"Spectrophotometric determination of risedronate and etidronate in pharmaceutical formulations via the molybdovanadate method","volume":"42","author":"Walash","year":"2009","journal-title":"Anal. Lett."},{"issue":"4","key":"10.1016\/j.jsps.2020.08.020_b0110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/jaoac\/93.4.1228","article-title":"Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies","volume":"93","author":"Walash","year":"2010","journal-title":"J. AOAC Int."},{"issue":"3","key":"10.1016\/j.jsps.2020.08.020_b0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpba.2008.05.028","article-title":"Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods","volume":"48","author":"Zacharis","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"22","key":"10.1016\/j.jsps.2020.08.020_b0120","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1002\/rcm.2755","article-title":"A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography\/tandem mass spectrometry","volume":"20","author":"Zhu","year":"2006","journal-title":"Rap. Comm. Mass Spec."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016420302000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016420302000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:23:26Z","timestamp":1736184206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016420302000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1319016420302000"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2020.08.020","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An eco-friendly HPLC-UV method for the determination of risedronate in its bulk and tablet dosage form with application to content uniformity, dissolution and stability testing","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2020.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}